{"id":68758,"date":"2026-02-21T13:56:34","date_gmt":"2026-02-21T13:56:34","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68758"},"modified":"2026-10-15T10:34:00","modified_gmt":"2026-10-15T10:34:00","slug":"tb-500","status":"publish","type":"product","link":"https:\/\/medsbase.com\/es\/product\/tb-500\/","title":{"rendered":"TB-500 (Timosina Beta-4)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Respuesta r\u00e1pida: \u00bfQu\u00e9 es TB-500?<\/h3>\n<p style=\"margin: 0;\"><strong>TB-500<\/strong> es un an\u00e1logo sint\u00e9tico de <strong>Thymosin Beta-4<\/strong>, a naturally occurring 43-amino-acid peptide with systemic healing activity. In published preclinical studies it binds G-actin, stimulates angiogenesis via the VEGF\/KDR pathway, and modulates TGF-beta inflammatory signaling. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Qu\u00e9 obtienes con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/es\/reviews\/\">opiniones de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada pedido est\u00e1 cubierto por nuestra <a href=\"https:\/\/medsbase.com\/es\/medsbase-re-shipment-assurance-policy\/\"><strong>Reshipment Assurance Policy<\/strong><\/a> \u2014 si tu paquete no llega en 20 d\u00edas laborables, lo reenviamos.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especificaci\u00f3n<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalle<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">77591-33-4<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>212<\/sub>H<sub>350<\/sub>N<sub>56<\/sub>O<sub>78<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">~4963 Da (N-acetil Timosina \u03b2-4 (1\u201343))<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Secuencia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Polvo liofilizado (o seg\u00fan suministro)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificado por HPLC, COA bajo solicitud)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Almacenamiento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (refrigerador) para stock de trabajo; \u221220 \u00b0C para almacenamiento a largo plazo de viales sin abrir. Reconstituido: 2\u20138 \u00b0C, usar en ~30 d\u00edas. Evitar agitaci\u00f3n vigorosa; los p\u00e9ptidos grandes se desnaturalizan al agitarlos. No congelar-descongelar la soluci\u00f3n reconstituida.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidad<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Agua bacteriost\u00e1tica (recomendada) o agua est\u00e9ril para periodos de uso m\u00e1s cortos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>\u00bfQu\u00e9 es TB-500?<\/h2>\n<p><strong>TB-500<\/strong> is the clinical designation for a synthetic analog of <strong>Timosina Beta-4 (TB4)<\/strong>, a naturally-occurring 43-amino-acid peptide hormone found in nearly every cell of the human body. TB4 is most abundant in platelets, and is released at sites of tissue damage where it orchestrates cell migration, angiogenesis, and anti-inflammatory signaling. The synthetic form \u2014 TB-500 \u2014 reproduces the biological activity of TB4 and is the most widely studied compound in this class. The TB4 sequence is <em>Ac-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES<\/em>, molecular weight approximately 4,963\u00a0Da. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For mechanism, published trial detail, and dosing considerations, see our full <a href=\"https:\/\/medsbase.com\/es\/tb-500-thymosin-beta-4-peptide-guide\/\">TB-500 guide<\/a>. <\/p>\n<h2>Mecanismo de acci\u00f3n: curaci\u00f3n sist\u00e9mica a trav\u00e9s de tres v\u00edas<\/h2>\n<p>TB-500 se distingue de la mayor\u00eda de los p\u00e9ptidos por su <strong>distribuci\u00f3n sist\u00e9mica y su larga vida media circulante<\/strong>, which allow a single administration to influence repair processes across multiple tissues simultaneously. The three primary mechanistic pathways in published studies:<\/p>\n<ul>\n<li><strong>Secuestro de G-actina<\/strong> \u2014 TB-500 binds monomeric actin (G-actin) via a central actin-binding motif (LKKTETQ). This preserves the cytoskeletal reservoir cells need to extend pseudopodia, migrate toward injury sites, and remodel after damage. Cell-migration assays in wound-edge studies consistently show enhanced migration rates in TB4-treated cells.<\/li>\n<li><strong>Angiog\u00e9nesis mediante se\u00f1alizaci\u00f3n VEGF\/KDR<\/strong> \u2014 TB-500 stimulates vascular endothelial migration and capillary formation through the VEGF receptor 2 (KDR) pathway. In ischemia-reperfusion and wound-healing studies this translates to faster restoration of perfusion at repair sites.<\/li>\n<li><strong>Se\u00f1alizaci\u00f3n antiinflamatoria mediante modulaci\u00f3n de TGF-beta<\/strong> \u2014 TB-500 reduces pro-inflammatory cytokine release and accelerates resolution of the inflammatory phase of healing. In cardiac ischemia studies, this has been linked to reduced infarct size and preserved cardiomyocyte function.<\/li>\n<\/ul>\n<p>Debido a que estos tres mecanismos se distribuyen por todo el cuerpo, TB-500 produce efectos en tejidos distantes del sitio de inyecci\u00f3n, una caracter\u00edstica que lo distingue de p\u00e9ptidos curativos m\u00e1s localizados como <a href=\"https:\/\/medsbase.com\/es\/bpc-157\/\">BPC-157<\/a>. The practical consequence: TB-500 protocols are dosed twice weekly rather than daily. <\/p>\n<h2>Published Evidence<\/h2>\n<p>TB-500 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Reparaci\u00f3n del m\u00fasculo esquel\u00e9tico<\/strong> \u2014 cin\u00e9tica de recuperaci\u00f3n sist\u00e9mica en modelos de roedores con lesiones por aplastamiento, distensiones y atrofia por desuso<\/li>\n<li><strong>Cardiac recovery<\/strong> \u2014 supervivencia de cardiomiocitos, tama\u00f1o del infarto y remodelaci\u00f3n vascular post-isqu\u00e9mica (Smart et al., Nature 2011; Bock-Marquette et al., Nature 2004)<\/li>\n<li><strong>Curaci\u00f3n de tendones y ligamentos<\/strong> \u2014 solo o en combinaci\u00f3n con <a href=\"https:\/\/medsbase.com\/es\/bpc-157\/\">BPC-157<\/a> in connective-tissue repair studies<\/li>\n<li><strong>Reparaci\u00f3n sist\u00e9mica de heridas<\/strong> \u2014 dermal and corneal wound-healing studies, especially where multiple tissue beds are affected<\/li>\n<li><strong>Hair cycle studies<\/strong> \u2014 follicular angiogenesis and hair-growth phase transitions in rodent study models<\/li>\n<li><strong>Reparaci\u00f3n vascular<\/strong> \u2014 endothelial cell migration, capillary formation, and ischemia studies<\/li>\n<li><strong>Comparative peptide studies<\/strong> \u2014 evaluaci\u00f3n comparativa frente a BPC-157 como el comparador can\u00f3nico de curaci\u00f3n local, o con <a href=\"https:\/\/medsbase.com\/es\/igf-1-lr3-peptide-guide\/\">IGF-1 LR3<\/a> y <a href=\"https:\/\/medsbase.com\/es\/ipamorelin-cjc-1295-stack-guide\/\">Ipamorelin\/CJC-1295<\/a> in growth-factor studies. See our <a href=\"https:\/\/medsbase.com\/es\/bpc-157-vs-tb-500-comparison-guide\/\">comparaci\u00f3n BPC-157 vs TB-500<\/a> para ver el an\u00e1lisis detallado.<\/li>\n<\/ul>\n<p>Para un contexto m\u00e1s amplio sobre d\u00f3nde encaja TB-500 en el panorama de p\u00e9ptidos curativos, consulte <a href=\"https:\/\/medsbase.com\/es\/best-peptides-for-muscle-recovery\/\">los mejores p\u00e9ptidos para la recuperaci\u00f3n muscular<\/a> cluster article and complementary compounds in the <a href=\"https:\/\/medsbase.com\/es\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a>. <\/p>\n<h2>Concentraciones y potencias disponibles<\/h2>\n<p>MedsBase ofrece TB-500 (Thymosin Beta-4 sint\u00e9tica) en los siguientes tama\u00f1os de viales liofilizados. Cada variante se env\u00eda en paquetes de 10, 20 o 30 viales con instrucciones completas de reconstituci\u00f3n:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Potencia del vial<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tama\u00f1os de paquete<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Pilot studies, titration, or short protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, matches common 2\u20132.5\u00a0mg dose-per-administration protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended studies, bulk prep, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 viales<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials offer lower per-mg cost and are generally preferred when users are modeling the 2\u20132.5\u00a0mg per-administration dose used across most published TB-500 protocols. <\/p>\n<h2>Comparativa \u2014 TB-500 frente a BPC-157<\/h2>\n<p>TB-500 y <a href=\"https:\/\/medsbase.com\/es\/bpc-157\/\">BPC-157<\/a> are the two most-cited healing peptides. They are often studied together because their mechanisms are complementary rather than overlapping \u2014 BPC-157 acts locally via growth-factor upregulation, TB-500 acts systemically via actin and angiogenesis pathways. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500 (Timosina Beta-4)<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Longitud<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43 amino\u00e1cidos (~4,963 Da)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15 amino\u00e1cidos (~1,419 Da)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Mecanismo primario<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Secuestro de G-actina, angiog\u00e9nesis, TGF-beta<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Regulaci\u00f3n al alza de VEGF + NO + receptor de GH<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Distribuci\u00f3n<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Sist\u00e9mica, se distribuye ampliamente<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">M\u00e1s localizada en el lugar de la inyecci\u00f3n<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Dosis t\u00edpica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\u20132,5 mg dos veces por semana, 4\u20136 semanas de carga<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\u2013500 mcg, 1\u20132 veces al d\u00eda<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Card\u00edaco, muscular sist\u00e9mico, vascular, capilar<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tend\u00f3n, ligamento, barrera intestinal<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Combinaci\u00f3n<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Se administra com\u00fanmente junto con BPC-157<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Se administra com\u00fanmente junto con TB-500<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For the full side-by-side methodological comparison and when users pick one over the other, read <a href=\"https:\/\/medsbase.com\/es\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500: qu\u00e9 p\u00e9ptido curativo para tu objetivo de recuperaci\u00f3n<\/a>. <\/p>\n<h2>Almacenamiento y reconstituci\u00f3n<\/h2>\n<p><strong>Antes de la reconstituci\u00f3n:<\/strong> almacene los viales liofilizados refrigerados a 2\u20138 \u00b0C en su envase original. El TB-500 liofilizado es estable en estas condiciones hasta 36 meses. Evite ciclos de congelaci\u00f3n-descongelaci\u00f3n en el polvo. <strong>Procedimiento de reconstituci\u00f3n:<\/strong> inyecte agua bacteriost\u00e1tica por la pared lateral del vial de p\u00e9ptidos (no directamente sobre el polvo liofilizado) seg\u00fan la tabla de diluci\u00f3n anterior. Agite suavemente, no <strong>ajuste<\/strong> agite y permita 5\u201310 minutos para una disoluci\u00f3n completa. Una soluci\u00f3n correctamente reconstituida debe ser clara e incolora. <strong>Despu\u00e9s de la reconstituci\u00f3n:<\/strong> almacene refrigerado a 2\u20138 \u00b0C y utilice en 30 d\u00edas para una estabilidad \u00f3ptima. No congele la soluci\u00f3n reconstituida: los ciclos de congelaci\u00f3n-descongelaci\u00f3n degradan la integridad del p\u00e9ptido. Deseche cualquier vial que presente turbidez, precipitado o decoloraci\u00f3n. <\/p>\n<h2 id=\"faqs\">Preguntas frecuentes<\/h2>\n<h3>What is TB-500 used for in studies?<\/h3>\n<p>TB-500 is used in studies investigating skeletal muscle repair, cardiac recovery, tendon and ligament healing, wound repair, hair-cycle studies, vascular repair, and systemic tissue regeneration. It is <strong>ajuste<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>\u00bfEn qu\u00e9 se diferencia el TB-500 del BPC-157?<\/h3>\n<p>TB-500 is a 43-amino-acid synthetic analog of Thymosin Beta-4 that acts systemically via G-actin binding, angiogenesis, and TGF-beta signaling. BPC-157 is a 15-amino-acid pentadecapeptide that acts mostly locally via VEGF, nitric oxide, and growth-hormone-receptor pathways. The two are often co-administered in studies because their mechanisms are complementary. <\/p>\n<h3>What is the typical TB-500 dose?<\/h3>\n<p>Los protocolos precl\u00ednicos publicados suelen utilizar 2\u20132,5 mg por administraci\u00f3n, aplicados dos veces por semana durante una fase de carga de 4\u20136 semanas, seguida de una fase de mantenimiento semanal. Un vial de 5 mg reconstituido con 2,0 mL de agua bacteriost\u00e1tica produce una concentraci\u00f3n de 2,5 mg\/mL \u2014 80 divisiones en una jeringa U-100 administran 2 mg. <\/p>\n<h3>\u00bfEst\u00e1 aprobado el TB-500 por la FDA?<\/h3>\n<p>No. TB-500 (synthetic Thymosin Beta-4) is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. <\/p>\n<h3>\u00bfC\u00f3mo se debe almacenar el TB-500?<\/h3>\n<p>Viales liofilizados: refrigerados a 2\u20138 \u00b0C en su envase original, estables hasta 36 meses. Soluci\u00f3n reconstituida: refrigerada a 2\u20138 \u00b0C, usar en 30 d\u00edas. No congelar la soluci\u00f3n reconstituida \u2014 los ciclos de congelaci\u00f3n-descongelaci\u00f3n degradan el p\u00e9ptido. <\/p>\n<h3>\u00bfC\u00f3mo reconstituyo el TB-500?<\/h3>\n<p>Siga la tabla de referencia de reconstituci\u00f3n anterior. A\u00f1ada agua bacteriost\u00e1tica por la pared lateral del vial (no directamente sobre el polvo liofilizado), agite suavemente y deje reposar 5\u201310 minutos para una disoluci\u00f3n completa. No <strong>ajuste<\/strong> Agitar el vial. <\/p>\n<h3>\u00bfQu\u00e9 concentraciones tiene MedsBase en stock?<\/h3>\n<p>MedsBase ofrece TB-500 en viales liofilizados de 2 mg, 5 mg y 10 mg. Cada concentraci\u00f3n est\u00e1 disponible en paquetes de 10, 20 o 30 viales. Todos los viales tienen una pureza HPLC del 99%+ y se proporciona un certificado de an\u00e1lisis bajo petici\u00f3n. <\/p>\n<h3>Can TB-500 and BPC-157 be stacked in studies?<\/h3>\n<p>Yes. TB-500 and BPC-157 are among the most commonly co-administered peptides in preclinical studies. Their mechanisms are complementary (systemic vs local, actin-binding vs growth-factor-upregulation), and combined protocols appear frequently in connective-tissue and muscle recovery. See our <a href=\"https:\/\/medsbase.com\/es\/bpc-157-vs-tb-500-comparison-guide\/\">gu\u00eda comparativa<\/a>. <\/p>\n<h3>\u00bfPor qu\u00e9 el TB-500 se dosifica con menos frecuencia que el BPC-157?<\/h3>\n<p>TB-500 has a longer circulating half-life and distributes systemically, so published studies protocols typically dose twice weekly. BPC-157 is more localized and commonly dosed once or twice daily in the same types of injury-model studies. <\/p>\n<h3>Does TB-500 cause side reported effects?<\/h3>\n<p>Published preclinical studies has reported a reasonable safety profile at typical doses. Published toxicology work has not identified off-target signals at standard doses. <\/p>\n<h3>\u00bfEs TB-500 lo mismo que la Thymosina Beta-4 completa?<\/h3>\n<p>TB-500 is marketed as a synthetic form of Thymosin Beta-4 (TB4). In commercial supply, what is sold as &#8220;TB-500&#8221; is typically the full 43-amino-acid TB4 molecule synthesized chemically. Some literature refers to shorter actin-binding fragments (LKKTETQ) as functional TB4 analogs in narrow contexts, but full-length TB4 is the dominant form. <\/p>\n<h3>\u00bfCu\u00e1l es la vida media de TB-500?<\/h3>\n<p>TB-500 (synthetic Thymosin Beta-4) has an estimated serum half-life of several days in preclinical studies \u2014 significantly longer than most GHRPs and site-specific healing peptides such as BPC-157. This extended half-life supports the less-frequent dosing schedules typically used in T\u03b24 protocols. <\/p>\n<h3>How long does TB-500 take to show effects in preclinical studies?<\/h3>\n<p>Preclinical studies using Thymosin Beta-4 in cardiac, skeletal muscle, and connective tissue models typically observe measurable effects over 2\u20134 week cycles. The systemic distribution and longer half-life compared to site-directed peptides mean TB-500 timelines are generally extended. <\/p>\n<h3>\u00bfPuedo pedir TB-500 para env\u00edo internacional?<\/h3>\n<p>S\u00ed. MedsBase env\u00eda TB-500 a todo el mundo desde nuestra red de env\u00edo dedicada a p\u00e9ptidos. Los pedidos exclusivos de p\u00e9ptidos califican para nuestro servicio de env\u00edo independiente de p\u00e9ptidos. Todos los pedidos se env\u00edan en embalaje con control de temperatura y seguimiento completo. <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">TB-500 se suele utilizar junto con BPC-157 \u2014 la angiog\u00e9nesis (BPC-157) m\u00e1s la reparaci\u00f3n del citoesqueleto (TB-500) proporciona una recuperaci\u00f3n de tejidos blandos m\u00e1s r\u00e1pida y completa que cualquiera de los p\u00e9ptidos por separado; nuestro <a href=\"\/es\/peptide-healing-stack\/\">Peptide Healing Stack (BPC-157 5 mg + TB-500 5 mg + agua bacteriost\u00e1tica)<\/a> env\u00eda el protocolo combinado en un solo paquete.<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/es\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tendon, ligament, gut recovery<\/li>\n<li><a href=\"\/es\/ipamorelin\/\"><strong>Ipamorelina<\/strong><\/a> \u2014 Agonista selectivo de grelina \u2014 pulso de GH limpio sin cortisol\/prolactina<\/li>\n<li><a href=\"\/es\/cjc-1295-with-dac\/\"><strong>CJC-1295 con DAC<\/strong><\/a> \u2014 An\u00e1logo de GHRH con vida media extendida<\/li>\n<li><a href=\"\/es\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<li><a href=\"\/es\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolic \/ regenerative support<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Lecturas adicionales<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Lee nuestra gu\u00eda completa basada en evidencia: <a href=\"https:\/\/medsbase.com\/es\/tb-500-thymosin-beta-4-peptide-guide\/\"><strong>TB-500 \u2014 mecanismo, datos de ensayos y perspectivas<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Favorece la regeneraci\u00f3n celular<br \/>\n\u2705 Mejora el modelado tisular<br \/>\n\u2705 Promueve la actividad de los fibroblastos<br \/>\n\u2705 Estimula la se\u00f1alizaci\u00f3n angiog\u00e9nica<br \/>\n\u2705 Mejora la estabilidad de la matriz extracelular<\/p>\n<p><strong>TB-500<\/strong> contiene compuesto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70987,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5441,5442,5443],"class_list":["post-68758","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-peptide","product_tag-tb-500","product_tag-thymosin-beta-4","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product\/68758","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/comments?post=68758"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media\/70987"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/media?parent=68758"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_brand?post=68758"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_cat?post=68758"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/es\/wp-json\/wp\/v2\/product_tag?post=68758"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}